Phosphagenics raising cash for R&D

Related tags Stock market

Australian biotech company Phosphagenics is looking to raise
A$11.25 million in a share placement to fund its core R&D
programme and other expenses.

The company that developed more bioavailable forms of vitamin E and C currently generates revenue from licensing these products to nutraceutical firms but it is also developing technology for its drug arm.

According to a statement yesterday, the share sale will help fund further research in both segments, including Phosphagenics' transdermal technology for use in a broad range of drugs.

Harry Rosen, president and executive director, said that he was very pleased with the response from investors.

"We believe it reflects their confidence in our ability to meet our milestone targets and deliver on our strategic plan,"​ he said.

Trading in the new shares on the Australian Stock Exchange and the London Stock Exchange's Alternative Investment Market is expected to start this week.

Related topics Suppliers Vitamins & premixes

Related news

Related products

show more

Optimize Nutritional Value with DuraLipo™

Optimize Nutritional Value with DuraLipo™

Content provided by INNOBIO Corporation Limited | 02-May-2024 | White Paper

INNOBIO's DuraLipo™ products encapsulates active ingredients within phospholipids, forming a genuine phospholipid bilayer structure.

Vitafoods Europe highlight: Fucoidan

Vitafoods Europe highlight: Fucoidan

Content provided by Marinova Pty Ltd | 08-Apr-2024 | Infographic

Fucoidans are bioactive compounds found naturally in brown seaweeds. Maritech® fucoidans are the world’s only high purity, certified organic fucoidans...

Innovation in convenient formats: vegan gummies

Innovation in convenient formats: vegan gummies

Content provided by Cambridge Commodities | 05-Mar-2024 | Product Brochure

Supplements and vitamins in pill form have been around for decades, but consumers are now seeking alternatives that fit with their busy lifestyles and...

Related suppliers

Follow us


View more